相关实验视频
Updated: Feb 25, 2026

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
2.3K
针对阿尔茨海默氏症护理管理的创新技术资源:范围审查
Maria Almeida1, Marta Campos Ferreira1,2, Carla Silva Fernandes3,4,5
1Faculty of Engineering of the University of Porto, Portugal.
Digital health
|February 24, 2026
概括
移动应用程序和可穿戴设备等技术工具有助于阿尔茨海默氏症.
科学领域:
- 老年学和健康信息学
- 神经退行性疾病管理技术和技术
背景情况:
- 阿尔茨海默病 (AD) 护理管理对患者,家庭,护理人员和医疗保健专业人员提出了重大挑战.
- 技术创新为支持AD护理提供了潜在的解决方案,但需要对现有工具进行全面的概述.
研究的目的:
- 系统地绘制和描述用于阿尔茨海默病护理管理的技术工具.
- 确定这些技术的关键功能和目标用户.
- 要突出目前的状态和技术在AD护理的局限性.
主要方法:
- 根据系统审查和元分析 (PRISMA) 框架的首选报告项目进行的范围审查.
- 在Scopus,PubMed,Web of Science和CINAHL数据库中进行了广泛的文献搜索.
- 包括专注于阿尔茨海默病护理和管理技术资源的研究.
主要成果:
- 包括23项研究,确定移动应用程序和可穿戴设备是最普遍的技术.
- 关键功能包括认知训练,位置跟踪,提醒,通信支持,跌倒检测和生命体征监测.
- 这些技术经常被整合到全面的解决方案中,以提高患者的护理和安全.
结论:
- 现有的技术主要旨在支持阿尔茨海默病患者和他们的护理人员.
- 显著的局限性包括缺乏现实世界的临床验证以及确保老年人和认知障碍患者的可用性方面的挑战.
- 需要进一步的研究来解决这些局限性,并优化在阿尔茨海默氏症护理中的技术采用.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.5K
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
7.5K
相关概念视频
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Documentation in Long-Term and Home Healthcare Setting
1.6K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.6K
Dementia
605
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
605